Argonaut Genomics is an early stage biotech focused on developing novel cancer antigens in solid tumors for therapeutic cancer vaccines and cell therapies. They envision a line of precision biologics based on tumor antigens widely shared across patients that can be manufactured as off-the-shelf products for treating and preventing cancer.